| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 1498-1507, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
RB Nagle, J Hao, JD Knox, BL Dalkin, V Clark and AE Cress
Department of Pathology, University of Arizona Health Sciences Center, Tucson, USA.
The progression of prostate carcinoma may be influenced by the biochemical nature of the basal lamina surrounding the primary carcinoma cells. As a first step toward understanding this process, the composition and structure of the basal lamina in normal prostate, prostatic intraepithelial neoplasia, and human carcinoma were determined. In addition, a comparison was made between the attachments of the normal basal cell to its underlying basal lamina and those made by primary prostate carcinoma. The normal basal cells form both focal adhesions and hemidesmosomal-like structures as observed by transmission electron microscopy. The normal basal cells exhibited a polarized distribution of hemidesmosomal associated proteins including BP180, BP230, HD1, plectin, laminin-gamma 2(B2t), collagen VII, and the corresponding integrin laminin receptors alpha 6 beta 1 and alpha 6 beta 4. The expression and distribution pattern of these proteins were retained in the prostate intraepithelial neoplasia lesions. In contrast, the carcinoma cells uniformly lacked hemidesmosomal structures, the integrin alpha 6 beta 4, BP180, laminin-gamma 2 (B2t), and collagen VII but did express BP230 (30%), plectin, HD1 (15%), and the integrin laminin receptors alpha 3 beta 1 and alpha 6 beta 1. These results suggest that, although a detectable basal lamina structure is present in carcinoma, its composition and cellular attachments are abnormal. The loss of critical cellular attachments may play a role in influencing the progression potential of prostate carcinoma.
This article has been cited by other articles:
![]() |
D. R. McCulloch, P. Akl, H. Samaratunga, A. C. Herington, and D. M. Odorico Expression of the Disintegrin Metalloprotease, ADAM-10, in Prostate Cancer and Its Regulation by Dihydrotestosterone, Insulin-Like Growth Factor I, and Epidermal Growth Factor in the Prostate Cancer Cell Model LNCaP Clin. Cancer Res., January 1, 2004; 10(1): 314 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. G. Sathyanarayana, A. Padar, M. Suzuki, R. Maruyama, H. Shigematsu, J.-T. Hsieh, E. P. Frenkel, and A. F. Gazdar Aberrant Promoter Methylation of Laminin-5-Encoding Genes in Prostate Cancers and Its Relationship to Clinicopathological Features Clin. Cancer Res., December 15, 2003; 9(17): 6395 - 6400. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parikka, T. Kainulainen, K. Tasanen, A. Vaananen, L. Bruckner-Tuderman, and T. Salo Alterations of Collagen XVII Expression During Transformation of Oral Epithelium to Dysplasia and Carcinoma J. Histochem. Cytochem., July 1, 2003; 51(7): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Udayakumar, M. L. Chen, E. L. Bair, D. C. von Bredow, A. E. Cress, R. B. Nagle, and G. T. Bowden Membrane Type-1-Matrix Metalloproteinase Expressed by Prostate Carcinoma Cells Cleaves Human Laminin-5 {beta}3 Chain and Induces Cell Migration Cancer Res., May 1, 2003; 63(9): 2292 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Davis, F. Buerger, and A. E. Cress Differential Regulation of a Novel Variant of the {alpha}6 Integrin, {alpha}6p Cell Growth Differ., March 1, 2002; 13(3): 107 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Haas, A. Berndt, K. J. Stiller, P. Hyckel, and H. Kosmehl A Comparative Quantitative Analysis of Laminin-5 in the Basement Membrane of Normal, Hyperplastic, and Malignant Oral Mucosa by Confocal Immunofluorescence Imaging J. Histochem. Cytochem., October 1, 2001; 49(10): 1261 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hao, L. Jackson, R. Calaluce, K. McDaniel, B. L. Dalkin, and R. B. Nagle Investigation into the Mechanism of the Loss of Laminin 5 ({{alpha}}3{beta}3{{gamma}}2) Expression in Prostate Cancer Am. J. Pathol., March 1, 2001; 158(3): 1129 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Edlund, T. Miyamoto, R. A. Sikes, R. Ogle, G. W. Laurie, M. C. Farach-Carson, C. A. Otey, H. E. Zhau, and L. W. K. Chung Integrin Expression and Usage by Prostate Cancer Cell Lines on Laminin Substrata Cell Growth Differ., February 1, 2001; 12(2): 99 - 107. [Abstract] [Full Text] |
||||
![]() |
C. Catusse, M. Polette, C. Coraux, H. Burlet, and P. Birembaut Modified Basement Membrane Composition During Bronchopulmonary Tumor Progression J. Histochem. Cytochem., May 1, 2000; 48(5): 663 - 670. [Abstract] [Full Text] |
||||
![]() |
C. M. Witkowski, G.T. Bowden, R. B. Nagle, and A. E. Cress Altered surface expression and increased turnover of the {alpha}6{beta}4 integrin in an undifferentiated carcinoma Carcinogenesis, February 1, 2000; 21(2): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Tran, R. B. Nagle, A. E. Cress, and R. L. Heimark N-Cadherin Expression in Human Prostate Carcinoma Cell Lines : An Epithelial-Mesenchymal Transformation Mediating Adhesion withStromal Cells Am. J. Pathol., September 1, 1999; 155(3): 787 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-Q. Zheng, A. S. Woodard, M. Fornaro, G. Tallini, and L. R. Languino Prostatic Carcinoma Cell Migration via {{alpha}}v{beta}3Integrin Is Modulated by a Focal Adhesion Kinase Pathway Cancer Res., April 1, 1999; 59(7): 1655 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fornaro, M. Manzotti, G. Tallini, A. E. Slear, S. Bosari, E. Ruoslahti, and L. R. Languino ß1C Integrin in Epithelial Cells Correlates with a Nonproliferative Phenotype : Forced Expression of ß1C Inhibits ProstateEpithelial Cell Proliferation Am. J. Pathol., October 1, 1998; 153(4): 1079 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Virolle, M.-N. Monthouel, Z. Djabari, J.-P. Ortonne, G. Meneguzzi, and D. Aberdam Three Activator Protein-1-binding Sites Bound by the Fra-2·JunD Complex Cooperate for the Regulation of Murine Laminin alpha 3A (lama3A) Promoter Activity by Transforming Growth Factor-beta J. Biol. Chem., July 10, 1998; 273(28): 17318 - 17325. [Abstract] [Full Text] [PDF] |
||||
![]() |
W H McLean, L Pulkkinen, F J Smith, E L Rugg, E B Lane, F Bullrich, R E Burgeson, S Amano, D L Hudson, K Owaribe, et al. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes & Dev., July 15, 1996; 10(14): 1724 - 1735. [Abstract] [PDF] |
||||
![]() |
T. L. Davis, I. Rabinovitz, B. W. Futscher, M. Schnolzer, F. Burger, Y. Liu, M. Kulesz-Martin, and A. E. Cress Identification of a Novel Structural Variant of the alpha 6 Integrin J. Biol. Chem., July 6, 2001; 276(28): 26099 - 26106. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |